class actions Archives

Does Data Sharing and Zoombombing Cause Actual Harm?
Gallery
Does Data Sharing and Zoombombing Cause Actual Harm?

Does Data Sharing and Zoombombing Cause Actual Harm?

December 22nd, 2020|Categories: Cyber Risk, Cyber Risk Litigation, HB Risk Notes|Tags: class actions, privacy law, zoombombing|

Legal Writer Law Street Media Zoom Says Data Sharing, Zoombombing Doesn't Cause Personal Harm Zoom is a good name for this company. It seems to have come out of nowhere to become the new verb for web meetings, robbing that distinction from many more established competitors like WebEx and GoToMeeting, maybe because they don't have cool web-sounding names, although people don't seem to be saying "let's Skype later," as much as they used to. Sure, we still "Facetime," but Zoom really shot to the top when it comes to name recognition. According to CNBC's Ari Levy, Zoom reported fiscal third-quarter revenue growth of more than 300% after seeing 355% expansion in the prior period. The company's stock was up almost seven-fold this year but "pulled back in November on positive news surrounding a coronavirus vaccine," Levy reported. And with success comes risk, especially when dealing with private data. Here is an excerpt of a post shared with the permission of Fastcase and Law Street Media. --Tom Hagy, HB Litigation Conferences Dec. 4, 2020 (San Francisco) -- On Wednesday [Dec. 2], in the Northern District of California, Zoom Video Communications filed a motion to dismiss the plaintiffs’ first amended consolidated class action complaint (FAC) on the grounds that the FAC failed to state a claim for which relief may be [...]

The Antitrust Case Against Google
Gallery
The Antitrust Case Against Google

The Antitrust Case Against Google

October 30th, 2020|Categories: Emerging Issues Webinars, Emerging Litigation & Risk, Emerging-On-Demand-CLE, HB Emerging Law Notes, Risk-On-Demand-CLE|Tags: antitrust, class actions, CLE, data privacy, data security, google antitrust, MoginRubin, Sherman Act|

The Antitrust Case Against Google Perspectives from highly regarded competition law attorneys, litigators, and economists. This overview and Q&A has been developed for advertisers, mobile device makers, app developers,corporate counsel, business writers, and search market participants. The U.S. Department of Justice and 11 states have filed a sweeping antitrust suit against Google alleging the tech giant abuses its position as "monopoly gatekeeper for the internet" to block competitors. The complaint says Google has used anticompetitive tactics to maintain and extend its monopolies in the markets for general search services, search advertising, and general search text advertising. The federal and state governments charge Google uses "exclusionary agreements, including tying arrangements" to "lock up distribution channels and block rivals." Google's considerable wealth helps make this happen. Google pays billions of dollars a year to distributors to secure their position as the default search engine, and prohibits these companies from dealing with Google competitors. Google's exclusionary strategy is being applied more harshly in newer technologies, such as voice assistants, and in its goal of dominating other platforms in the IoT category, such as smart speakers, home appliances, and autonomous cars. Without a court order, the government plaintiffs say, "Google will continue executing its anticompetitive strategy, crippling the competitive process, reducing consumer choice, and stifling competition." What does all of this mean to [...]

Class Actions Weekly Roundup from Top Class Actions

March 31st, 2018|Categories: HB Tort Notes|Tags: class actions, facebook class action, facial recognition, mislabeled, top class actions, xarelto|

This roundup is prepared exclusively for HB Litigation Conferences by: Walmart Class Action Claims Glucosamine Tablets are Mislabeled Walmart has been hit with a class action lawsuit claiming that their store brand glucosamine tablets are mislabeled. Plaintiffs Cynthia Parker, Reba Garth, Margaret Herrin, and Shirley Reinhard allege that Walmart misrepresents its store-brand glucosamine sulfate dietary… Read More Sorin 3T Heater Cooler Lawsuit Alleges Serious M. Chimaera Bacterial Infection An Indiana man has filed a Sorin 3T heater cooler lawsuit against LivaNova PLC, alleging their cardiac heater cooler device had caused him to develop a potentially fatal infection. The claimant filed the Sorin 3T heater cooler… Read More Coca-Cola Seeks Dismissal of Diet Coke Class Action Lawsuit Coca-Cola asked a New York federal court to toss a class action lawsuit alleging the company’s use of the name “Diet Coke” is misleading. The company argues that claims against its use of the word “diet” in… Read More Couple Files Stryker Hip Recall Lawsuit Over Metallosis Complications Thousands of hip implants were affected by a Stryker hip recall after they were linked with serious complications, including metallosis. Some patients affected by these major side effects have turned to litigation, hoping to regain some… Read More Facebook Class Action Challenges Facial Recognition Technology Facebook faces a new class action lawsuit alleging that the social media site captured and stored biometric information of non-users [...]

Top Class Actions’ Top Trends Affecting Class Actions in 2018

March 31st, 2018|Categories: HB Tort Notes|Tags: class actions, scott hardy, top class actions|

Editor's Note: This article was written by Kim Gale at Top Class Actions and is reprinted here with the permission of the publisher. Scott Hardy, the company's President & CEO, is one of the speakers featured at HB's Class Action Mastery conference May 9-11, 2018 in New York. Top Class Actions is sponsoring that event and its companion program, Mass Tort Med School, the same week. As we come close to rounding out the first quarter of 2018, it is clear that several class action lawsuit trends from 2017 will continue to ripple through the court system this year. Class Action Lawsuit Stats Did you know three areas are responsible for a third of all class action lawsuits filed in the U.S.? The federal courts in California, Southern District (Miami) of Florida, and the Eastern District (Brooklyn) of New York keep lawyers and judges the busiest. In the initial nine months of 2017, a total 3,136 federal class action lawsuits were filed in those areas alone, according to an article published Dec. 9, 2017 by PorterWright.com. These statistics are apt to change because new Supreme Court decisions (Bristol-Myers Squibb v. Superior Court of California and BNSF Railway Co. v. Tyrrell) rein in a court’s jurisdiction and ability to litigate matters when residents from outside the court’s state make claims. These new decisions mean a defendant [...]

Mass Tort Med School | May 9-11, 2018 | New York

January 11th, 2018|Categories: HB Risk Notes|Tags: abilify, asbestos talc, benicar, class actions, flu vaccine, hernia mesh, influenza, mass torts, mass torts conference, opioid litigation, personal injury, plaintiff conference, Product Liability, talc, testosterone, vaginal mesh|

CHAIRS Vicki Maniatis | Partner | Sanders Phillips Grossman, LLC Both federal and state judges have appointed Vicki as lead counsel on various Plaintiffs’ steering committees in well-known mass tort cases. She has received several distinguished honors as a top attorney and is active in the New Jersey Association for Justice, the American Association for Justice, and the New York State Trial Lawyers Association. Vicki is one of the founding faculty members of the Mass Tort Med School. Read more. Dr. John Restaino, MPH, JD, DPM | Senior Of-Counsel Attorney | Sanders Phillips Grossman, LLC John works with the firm on several litigations including the opioid "mass fatality crisis" litigation, transvaginal mesh and talc/ovarian cancer litigation. John practiced surgery of the foot and ankle from 1980 to 1990, prescribing opioids during that time and has practiced at the law since 1991. He obtained his MPH from the Division of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in 2008. Read more. Harris L. Pogust | Partner | Pogust Braslow & Millrood LLC Harris has spent his career representing people who have been injured not only by the negligence of others, but also by the greed and intentional actions of large corporations across the country, as well as the federal government. For more than 25 years, Harris has been litigating, bringing to trial, and settling claims, and [...]

Mass Tort Judicial Forum w/ Corodemus | April 23, 2018

January 10th, 2018|Categories: HB Risk Notes|Tags: class actions, complex litigation, corodemus conference, corodemus forum, jams conference, judicial forum, litigation CLE, mass torts, Product Liability|

We were proud to have worked with Judge Corodemus for 8 years! She truly is a highly regarded and intelligent leader who dedicates herself to bringing complex claims to resolution. Plus, she's alot of fun! Scroll down, peruse the agenda and list of speakers. We have phased live conferences out and no longer offer it as a service. Please visit our home page for a menu of all we do. Sponsors Special thanks to our friends at Drinker Biddle! HB's Recommended Readings State Court Jurisdiction in the 21st Century by Prof. Adam N. Steinman for the Pound Civil Justice Institute. Download it now. An Assessment of the Real World Implications of the New Jersey Supreme Court’s McCarrell Decision by William J. Beausoleil of Hughes Hubbard & Reed LLP. Read it now. Accutane Plaintiffs Overcome the “Super-Presumption” That FDA-Approved Warnings About Drugs are Adequate by Bruce D. Greenberg, Lite DePalma Greenberg, LLC. Read it now. Another Accutane Decision and a Big Win for Plaintiffs by Greenberg. Read it now. Merck’s petition to the U.S. Supreme Court in Merck Sharp & Dohme v. Albrecht on the issue of whether FDA approval insulates it from state law failure-to-warn claims. Read it now. The Supreme Court’s 2009 ruling against preemption of state law failure-to-warn claims in Wyeth v. Levine. Read it now. The Third Circuit U.S. Court of Appeals’ March 2017 ruling in In Re: Fosamax Product Liability Litigation which [...]